Touchlight and New England Biolabs® Unveil EnClose™ Cell-free dbDNA™ Synthesis Kit to Accelerate Next Generation DNA and RNA Therapeutic Development
LONDON, UK, March 18, 2026 / Biotech Newswire / -- Touchlight, in collaboration with New England Biolabs (NEB®), announces the launch of the EnClose™ Cell-free dbDNA™ Synthesis Kit, a new benchtop solution enabling rapid enzymatic production of Touchlight’s proprietary doggybone DNA™ (dbDNA™).